An alarming rate of deaths caused due to drink and drive scenarios are increasingly becoming a matter of concern for government authorities worldwide. Thus, innovations in the healthcare industry are generating incremental opportunities for companies in the roadside drug testing devices market. For instance, in December 2019, Abbott-a global leader in medical devices announced the launch of the SoToxa™ Mobile Test System, which is acquiring global recognition. Novel roadside drug testing devices are gaining importance to combat drug-impaired driving and ensure road safety.
Companies in the roadside drug testing devices market are increasing their production capabilities to develop handheld devices. This is evident since handheld modality segment is estimated for exponential growth during the forecast period and the global roadside drug testing devices market is expected to reach a value of ~US$ 924 Mn by the end of 2027. Stakeholders in law enforcement are using oral fluid swabs that are inserted in handheld analyzers to detect marijuana and other drugs within minutes.
As suggested by the Swinburne University of Technology, drug users are apparently surpassing the number of alcohol consumers in Australia, resulting in high rates of fatal crashes. Hence, companies in the roadside drug testing devices market should tap opportunities in Australia to increase the uptake of detection devices. Likewise, companies in the market for roadside drug testing devices are collaborating with researchers to increase R&D in psychology and neurosciences to ascertain if drivers under the influence of cannabis are more likely to meet with an accident, as compared to alcohol consumers.
With the introduction of driving simulators, companies in the roadside drug testing devices market are able to conduct better analysis of cognitive behavior and psychomotor functioning of individuals through the help of clinical trials. Companies in the market for roadside drug testing devices are gaining important insights through research findings carried out as a result of collaborations between universities and medical institutes.
Breathalyzers are becoming increasingly mainstream in the detection of alcohol in the roadside drug testing devices market. However, there is a growing need for breathalyzers that are also capable of detecting marijuana. Hence, researchers in the market for roadside drug testing devices are increasing R&D to develop novel breathalyzers that detect THC. For instance, an interdisciplinary team at the University of Pittsburgh, developed a breathalyzer using nanotechnology sensors that detect THC. Thus, innovative breathalyzers are increasingly becoming the gold standard for THC detection and manufacturers should collaborate with researchers to innovate in devices. This trend has supported the exponential growth of THC among other substance types in the roadside drug testing devices market.
Companies in the roadside drug testing devices market are increasing research in developing breathalyzers using carbon nanotubes and nanotechnology sensors to meet requirements of mass spectrometry. This trend is prominent in the U.S. since legalization of recreational marijuana has raised concerns about the enforcement of DUI (Driving Under the Influence) laws in the region.
Since THC drugs segment is anticipated for exponential growth in the market for roadside drug testing devices, manufacturers are introducing breakthrough innovations that are a novel addition to the cannabis detection sector. For instance, Cannabix Technologies- a supplier of drug detection tools has announced that its scientific team has come up with a proprietary method-Field asymmetric waveform ion mobility spectrometry (FAIMS) to detect THC. Such innovations have contributed toward the modest of the roadside drug testing devices market, which is expected to expand at a CAGR of ~4% during the forecast period. Hence, manufacturers are focusing on innovating breathalyzers using high-field ion mobility and mass spectrometry.
Companies in the roadside drug testing devices market are developing lightweight devices that are user-friendly and store numerous samples. They are increasing efforts to develop devices that are capable of detecting extremely low quantities of THC analytes. Thus, innovative breathalyzers are increasingly replacing conventional breath analyzing techniques.
Analysts’ Viewpoint
The roadside drug testing devices market is projected for exponential growth in North America. Lack of efficient DUI laws in the U.S. are fueling the demand for drug testing devices. Manufacturers are increasing efforts to meet the demand for breath analyzers that can detect extremely low quantities of THC analytes.
Increased research spending has become the key focus point of companies in the market landscape. However, incidences of false positives from poppy seeds and tea in drug testing devices act as barriers for market growth. Hence, manufacturers should develop devices that can differentiate between drugs or alcohol and food items that are merely in the system of an individual.
Roadside Drug Testing Devices Market – Segmentation
Substance |
Drugs
Alcohol |
Sample Type |
Saliva Sweat Urine Others |
Modality |
Handheld Standalone |
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
Roadside drug testing devices market is expected to reach a value of ~US$ 924 Mn by the end of 2027
Roadside drug testing devices market is projected to expand at a CAGR of ~4% from 2019 to 2027
Roadside drug testing devices market is driven by increase in the number of drug and alcohol abusers
North America accounted for a major share of the global roadside drug testing devices market
Key players in the global roadside drug testing devices market are Drägerwerk AG & Co. KgaA, Abbott Laboratories, Oranoxis, Inc., CareHealth America
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Roadside Drug Testing Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Pricing Analysis
4.1.2. Industry Evolution/ Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.4. Global Roadside Drug Testing Devices Market Analysis and Forecast, 2017–2027
5. Market Outlook
5.1. Technological Advancements
5.2. Roadside Drugs Testing Programs, by Country/Region
5.3. Regulatory Scenario Assessment
5.4. Key Industry Events (mergers, acquisitions, collaborations, launch & approvals, etc.)
6. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Modality
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Modality, 2017–2027
6.3.1. Handheld
6.3.2. Standalone
6.4. Market Attractiveness Analysis, by Modality
7. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Substance
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Substance, 2017–2027
7.3.1. Drugs
7.3.1.1. Tetrahydrocannabinol (THC)
7.3.1.2. Cocaine
7.3.1.3. Amphetamine
7.3.1.4. Benzodiazepines
7.3.1.5. Opioids
7.3.1.6. Others
7.3.2. Alcohol
7.4. Market Attractiveness Analysis, by Substance
8. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Sample Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Sample Type, 2017–2027
8.3.1. Saliva
8.3.2. Sweat
8.3.3. Urine
8.3.4. Others
8.4. Market Attractiveness Analysis, by Substance
9. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Region
9.1. Key Findings / Developments
9.2. Market Value Forecast, by Region, 2017–2027
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Roadside Drug Testing Devices Market Analysis and Forecast
10.1. Key Findings
10.2. Market Value Forecast, by Modality, 2017–2027
10.2.1. Handheld
10.2.2. Standalone
10.3. Market Value Forecast, by Substance, 2017–2027
10.3.1. Drugs
10.3.1.1. Tetrahydrocannabinol (THC)
10.3.1.2. Cocaine
10.3.1.3. Amphetamine
10.3.1.4. Benzodiazepines
10.3.1.5. Opioids
10.3.1.6. Others
10.3.2. Alcohol
10.4. Market Value Forecast, by Sample Type, 2017–2027
10.4.1. Saliva
10.4.2. Sweat
10.4.3. Urine
10.4.4. Others
10.5. Market Attractiveness Analysis, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Modality
10.6.2. By Substance
10.6.3. By Sample Type
10.6.4. By Country
11. Europe Roadside Drug Testing Devices Market Analysis and Forecast
11.1. Key Findings
11.2. Market Value Forecast, by Modality, 2017–2027
11.2.1. Handheld
11.2.2. Standalone
11.3. Market Value Forecast, by Substance, 2017–2027
11.3.1. Drugs
11.3.1.1. Tetrahydrocannabinol (THC)
11.3.1.2. Cocaine
11.3.1.3. Amphetamine
11.3.1.4. Benzodiazepines
11.3.1.5. Opioids
11.3.1.6. Others
11.3.2. Alcohol
11.4. Market Value Forecast, by Sample Type, 2017–2027
11.4.1. Saliva
11.4.2. Sweat
11.4.3. Urine
11.4.4. Others
11.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Modality
11.6.2. By Substance
11.6.3. By Sample Type
11.6.4. By Country/Sub-region
12. Asia Pacific Roadside Drug Testing Devices Market Analysis and Forecast
12.1. Key Findings
12.2. Market Value Forecast, by Modality, 2017–2027
12.2.1. Handheld
12.2.2. Standalone
12.3. Market Value Forecast, by Substance, 2017–2027
12.3.1. Drugs
12.3.1.1. Tetrahydrocannabinol (THC)
12.3.1.2. Cocaine
12.3.1.3. Amphetamine
12.3.1.4. Benzodiazepines
12.3.1.5. Opioids
12.3.1.6. Others
12.3.2. Alcohol
12.4. Market Value Forecast, by Sample Type, 2017–2027
12.4.1. Saliva
12.4.2. Sweat
12.4.3. Urine
12.4.4. Others
12.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Modality
12.6.2. By Substance
12.6.3. By Sample Type
12.6.4. By Country/Sub-region
13. Latin America Roadside Drug Testing Devices Market Analysis and Forecast
13.1. Key Findings
13.2. Market Value Forecast, by Modality, 2017–2027
13.2.1. Handheld
13.2.2. Standalone
13.3. Market Value Forecast, by Substance, 2017–2027
13.3.1. Drugs
13.3.1.1. Tetrahydrocannabinol (THC)
13.3.1.2. Cocaine
13.3.1.3. Amphetamine
13.3.1.4. Benzodiazepines
13.3.1.5. Opioids
13.3.1.6. Others
13.3.2. Alcohol
13.4. Market Value Forecast, by Sample Type, 2017–2027
13.4.1. Saliva
13.4.2. Sweat
13.4.3. Urine
13.4.4. Others
13.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Substance
13.6.2. By Substance
13.6.3. By Sample Type
13.6.4. By Country/Sub-region
14. Middle East & Africa Roadside Drug Testing Devices Market Analysis and Forecast
14.1. Key Findings
14.2. Market Value Forecast, by Modality, 2017–2027
14.2.1. Handheld
14.2.2. Standalone
14.3. Market Value Forecast, by Substance, 2017–2027
14.3.1. Drugs
14.3.1.1. Tetrahydrocannabinol (THC)
14.3.1.2. Cocaine
14.3.1.3. Amphetamine
14.3.1.4. Benzodiazepines
14.3.1.5. Opioids
14.3.1.6. Others
14.3.2. Alcohol
14.4. Market Value Forecast, by Sample Type, 2017–2027
14.4.1. Saliva
14.4.2. Sweat
14.4.3. Urine
14.4.4. Others
14.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Modality
14.6.2. By Substance
14.6.3. By Sample Type
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis, by Company, 2018
15.3. Company Profiles
15.3.1. Abbott
15.3.1.1. Company Overview
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Drägerwerk AG & Co. KGaA.
15.3.2.1. Company Overview
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. UriTox, LLC
15.3.3.1. Company Overview
15.3.3.2. Growth Strategies
15.3.3.3. SWOT Analysis
15.3.4. Oranoxis, Inc.
15.3.4.1. Company Overview
15.3.4.2. Growth Strategies
15.3.4.3. SWOT Analysis
15.3.5. Securetec
15.3.5.1. Company Overview
15.3.5.2. Growth Strategies
15.3.5.3. SWOT Analysis
15.3.6. CareHealth America
15.3.6.1. Company Overview
15.3.6.2. Growth Strategies
15.3.6.3. SWOT Analysis
15.3.7. MAVAND Solutions GmbH
15.3.7.1. Company Overview
15.3.7.2. Growth Strategies
15.3.7.3. SWOT Analysis
15.3.8. Pacific Data Systems Pty Ltd.
15.3.8.1. Company Overview
15.3.8.2. Growth Strategies
15.3.8.3. SWOT Analysis
List of Tables
Table 01: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027
Table 02: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 03: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027
Table 04: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 05: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 06: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027
Table 07: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 08: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027
Table 09: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 10: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 11: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027
Table 12: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 13: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027
Table 14: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 15: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027
Table 17: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 18: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027
Table 19: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 20: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027
Table 22: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 23: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027
Table 24: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 25: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 26: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027
Table 27: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 28: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027
Table 29: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 30: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
List of Figures
Figure 01: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, 2017–2027
Figure 02: Global Roadside Drug Testing Devices Market Value Share, by Substance, 2018
Figure 03: Global Roadside Drug Testing Devices Market Value Share, by Sample Type, 2018
Figure 04: Global Roadside Drug Testing Devices Market Value Share, by Modality, 2018
Figure 05: Global Roadside Drug Testing Devices Market Value Share, by Region, 2018
Figure 06: Global Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027
Figure 07: Global Roadside Drug Testing Devices Market Value Share Analysis, by Drugs, 2018 and 2027
Figure 08: Global Roadside Drug Testing Devices Market Attractiveness Analysis, by Drugs, 2019–2027
Figure 09: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs,
Figure 10: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Alcohol, 2017–2027
Figure 11: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Tetrahydrocannabinol (THC), 2017–2027
Figure 12: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cocaine, 2017–2027
Figure 13: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Amphetamine, 2017–2027
Figure 14: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Benzodiazepines, 2017–2027
Figure 15: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Opioids, 2017–2027
Figure 16: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 17: Global Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027
Figure 18: Global Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027
Figure 19: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Saliva, 2017–2027
Figure 20: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 21: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urine, 2017–2027
Figure 22: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Sweat, 2017–2027
Figure 23: Global Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027
Figure 24: Global Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027
Figure 25: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Handheld, 2017–2027
Figure 26: Global Roadside Drug Testing Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Standalone, 2017–2027
Figure 27: Global Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027
Figure 28: Global Roadside Drug Testing Devices Market Value Share Analysis, by Region, 2018 and 2027
Figure 29: Global Roadside Drug Testing Devices Market Attractiveness Analysis, by Region, 2019–2027
Figure 30: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 31: North America Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027
Figure 32: North America Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027
Figure 33: North America Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027
Figure 34: North America Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027
Figure 35: North America Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027
Figure 36: North America Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027
Figure 37: North America Roadside Drug Testing Devices Market Value Share Analysis, by Country, 2018 and 2027
Figure 38: North America Roadside Drug Testing Devices Market Attractiveness Analysis, by Country, 2019–2027
Figure 39: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 40: Europe Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027
Figure 41: Europe Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027
Figure 42: Europe Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027
Figure 43: Europe Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027
Figure 44: Europe Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027
Figure 45: Europe Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027
Figure 46: Europe Roadside Drug Testing Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 47: Europe Roadside Drug Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 48: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 49: Asia Pacific Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027
Figure 50: Asia Pacific Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027
Figure 51: Asia Pacific Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027
Figure 52: Asia Pacific Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027
Figure 53: Asia Pacific Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027
Figure 54: Asia Pacific Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027
Figure 55: Asia Pacific Roadside Drug Testing Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 56: Asia Pacific Roadside Drug Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 57: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 58: Latin America Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027
Figure 59: Latin America Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027
Figure 60: Latin America Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027
Figure 61: Latin America Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027
Figure 62: Latin America Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027
Figure 63: Latin America Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027
Figure 64: Latin America Roadside Drug Testing Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 65: Latin America Roadside Drug Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 66: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 67: Middle East & Africa Roadside Drug Testing Devices Market Value Share Analysis, by Substance, 2018 and 2027
Figure 68: Middle East & Africa Roadside Drug Testing Devices Market Attractiveness Analysis, by Substance, 2019–2027
Figure 69: Middle East & Africa Roadside Drug Testing Devices Market Value Share Analysis, by Sample Type, 2018 and 2027
Figure 70: Middle East & Africa Roadside Drug Testing Devices Market Attractiveness Analysis, by Sample Type, 2019–2027
Figure 71: Middle East & Africa Roadside Drug Testing Devices Market Value Share Analysis, by Modality, 2018 and 2027
Figure 72: Middle East & Africa Roadside Drug Testing Devices Market Attractiveness Analysis, by Modality, 2019–2027
Figure 73: Middle East & Africa Roadside Drug Testing Devices Market Value Share Analysis, by Country/Sub-region,
Figure 74: Middle East & Africa Roadside Drug Testing Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 75: Global Roadside Drugs Testing Devices Analysis, by Top Company Ranking, 2018